Table 4.
Univariate analysis | Multivariate analysis | |||||
---|---|---|---|---|---|---|
OR | 95% CI | p value | OR | 95% CI | p value | |
Male | 1.40 | 0.578–3.731 | 0.419 | |||
Age | 1.02 | 0.930–1.123 | 0.645 | |||
NYHA > 3 | 0.91 | 0.250–3.367 | 0.896 | |||
Hypertension | 0.46 | 0.162–1.306 | 0.145 | |||
Diabetes | 2.26 | 0.858–5.952 | 0.099 | |||
Atrial fibrillation | 2.97 | 1.111–7.920 | 0.023 | 2.53 | 0.886–6.929 | 0.081 |
Coronary revascularization | 1.96 | 0.727–5.307 | 0.183 | |||
eGFR | 0.99 | 0.964–1.019 | 0.517 | |||
BNP | 1.00 | 0.999–1.000 | 0.969 | |||
LVEF (Simpson) | 0.98 | 0.941–1.029 | 0.488 | |||
AVA-I | 0.77 | 0.032–18.946 | 0.137 | |||
LVEDV | 0.99 | 0.970–1.012 | 0.356 | |||
LVESV | 1.01 | 0.978–1.035 | 0.671 | |||
Balloon size | 0.98 | 0.941–1.029 | 0.488 | |||
RVP time | 1.03 | 0.992–1.060 | 0.140 | |||
Long RVP (> 35 s) | 2.84 | 1.034–7.510 | 0.043 | 1.59 | 0.534–4.594 | 0.396 |
INOUE-BALLOON without RVP | 0.22 | 0.061–0.768 | 0.018 | 0.27 | 0.059–0.952 | 0.041 |
AVA-I AVA indexed, eGFR estimated glomerular filtration rate, LVEDV left ventricular end-diastolic volume, LVEF left ventricular ejection fraction, LVESV left ventricular end-systolic volume, MI myocardial infarction, NYHA New York Heart Association, RVP rapid ventricular pacing